Adicet Bio (ACET) Competitors

Adicet Bio (NASDAQ:ACET) and W.W. Grainger (NYSE:GWW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Do analysts prefer ACET or GWW?

Adicet Bio presently has a consensus price target of $7.50, indicating a potential upside of 670.50%. W.W. Grainger has a consensus price target of $1,148.56, indicating a potential upside of 13.94%. Given Adicet Bio's stronger consensus rating and higher possible upside, equities research analysts clearly believe Adicet Bio is more favorable than W.W. Grainger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adicet Bio	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
W.W. Grainger	1 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.23

Does the MarketBeat Community believe in ACET or GWW?

W.W. Grainger received 247 more outperform votes than Adicet Bio when rated by MarketBeat users. However, 58.28% of users gave Adicet Bio an outperform vote while only 53.37% of users gave W.W. Grainger an outperform vote.

Company	Underperform	Outperform
Adicet Bio	Outperform Votes 299 58.28%	Underperform Votes 214 41.72%
W.W. Grainger	Outperform Votes 546 53.37%	Underperform Votes 477 46.63%

Which has more volatility & risk, ACET or GWW?

Adicet Bio has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, W.W. Grainger has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.

Is ACET or GWW more profitable?

W.W. Grainger has a net margin of 11.12% compared to Adicet Bio's net margin of 0.00%. W.W. Grainger's return on equity of 52.43% beat Adicet Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adicet Bio	N/A	-53.85%	-46.45%
W.W. Grainger	11.12%	52.43%	22.15%

Do insiders and institutionals hold more shares of ACET or GWW?

83.9% of Adicet Bio shares are held by institutional investors. Comparatively, 80.7% of W.W. Grainger shares are held by institutional investors. 19.1% of Adicet Bio shares are held by company insiders. Comparatively, 9.5% of W.W. Grainger shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to ACET or GWW?

In the previous week, W.W. Grainger had 29 more articles in the media than Adicet Bio. MarketBeat recorded 30 mentions for W.W. Grainger and 1 mentions for Adicet Bio. W.W. Grainger's average media sentiment score of 1.35 beat Adicet Bio's score of 0.00 indicating that W.W. Grainger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adicet Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
W.W. Grainger	24 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, ACET or GWW?

W.W. Grainger has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than W.W. Grainger, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adicet Bio	$24.99M	3.21	-$142.66M	-$1.71	-0.57
W.W. Grainger	$17.17B	2.86	$1.91B	$38.71	26.04

Summary

W.W. Grainger beats Adicet Bio on 11 of the 19 factors compared between the two stocks.